Literature DB >> 7345684

Lysophospholipase 1 in Trypanosoma brucei.

L Sage, P N Hambrey, G M Werchola, A Mellors, I R Tizard.   

Abstract

Protein fractions from Trypanosoma brucei brucei showed lysophospholipase 1 activity (E.E.3.1.1.5), against the substrate 1-acyl-sn-glycero-3-phosphocholine, and also phospholipase A1 activity (E.C.3.1.1.4) by hydrolysis of the 1-acyl bond of 1,2-diacyl-sn-glycero-3-phosphocholine. Both enzyme activities were eluted together and showed a 12-fold purification following Sephacryl S-200 column chromatography. A final 96-fold increase in activity was obtained by electrophoresis on nondenaturing polyacrylamide gels to yield a band containing both enzymic activities. Phospholipase A1 showed maximum activity between pH 6.0--8.5 and lysophospholipase 1 had a pH optimum of 8.5. Both activities were found mainly in the soluble fraction of disrupted trypanosomes and were similarly inhibited by N-ethylmaleimide and p-chloromercuribenzoic acid. Although Triton X-100 stimulated phospholipase A1 activity, it inhibited lysophospholipase 1 activity. The Km value for the lysophospholipase 1 was found to be 0.15 mM. It was not possible to resolve separate activities for lysophospholipase 1 and phospholipase A1 and the ratio of the two activities was approximately 1 : 10 for a variety of preparations and treatments. It is probable that a single enzyme displays both activities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7345684

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  8 in total

1.  Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.

Authors:  Fred Widmer; Lesley C Wright; Daniel Obando; Rosemary Handke; Ranjini Ganendren; David H Ellis; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease.

Authors:  M Wainszelbaum; E Isola; S Wilkowsky; J J Cannata; J Florin-Christensen; M Florin-Christensen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  A novel phospholipase from Trypanosoma brucei.

Authors:  Gregory S Richmond; Terry K Smith
Journal:  Mol Microbiol       Date:  2007-02       Impact factor: 3.501

5.  Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.

Authors:  Shankar Mukherjee; Nikaeta Sadekar; Anthony W Ashton; Huan Huang; David C Spray; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

6.  Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.

Authors:  Shankar Mukherjee; Fabiana S Machado; Huang Huang; Helieh S Oz; Linda A Jelicks; Cibele M Prado; Wade Koba; Eugene J Fine; Dazhi Zhao; Stephen M Factor; J Elias Collado; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

7.  Phospholipases a in trypanosomatids.

Authors:  María Laura Belaunzarán; Estela María Lammel; Elvira Luisa Durante de Isola
Journal:  Enzyme Res       Date:  2011-04-05

8.  Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interaction.

Authors:  Karen C M Moraes; Lívia F Diniz; Maria Terezinha Bahia
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04       Impact factor: 2.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.